HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California. Show more
Location: 331 E. Evelyn Avenue, Mountain View, CA, 94041, United States | Website: https://www.heartflow.com | Industry: Health Information Services | Sector: Healthcare
Market Cap
2.384B
52 Wk Range
$25.75 - $41.22
Previous Close
$28.00
Open
$28.11
Volume
377,142
Day Range
$27.58 - $29.07
Enterprise Value
2.121B
Cash
291.2M
Avg Qtr Burn
-14.37M
Insider Ownership
2.42%
Institutional Own.
69.83%
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
